Friday, June 19, 2020 Daily Archives

COVID-19 vaccine rush magnifying glass demand, says Stevanato Group

by

Gerresheimer, The Stevanato Group, and SCHOTT have pledged to safeguard the supply of glass vials as demand from COVID-19 related projects gets set to skyrocket. All parts of the biopharma supply chain will be called upon to support the increasing numbers of COVID-19 vaccines entering and progressing through the clinic. As such, three glass and primary packaging firms have come together to issue a statement promising to work together and with industry to ensure supply of such elements throughout all…

June 19, 2020

Imperial College London takes RNA COVID vaccine into clinic

by

A vaccine candidate that allegedly turns cells in the body into ‘mini-antibody producing factories’ against COVID-19 has begun first-in-human clinical trials. The latest effort in combatting COVID-19 comes form the UK’s Imperial College London, with its vaccine candidate beginning Phase I trials this week. The vaccine is being developed through over £41 million ($51 million) of UK government funds and is based on a self-amplifying RNA technology. “The way the vaccine works is quite different from other approaches in that…

June 19, 2020